Autor: |
Dimtsas GS; First Department of Ophthalmology, National and Kapodistrian University of Athens, 'G. Gennimatas' General Hospital, 11527 Athens, Greece., Tsiogka A; First Department of Ophthalmology, National and Kapodistrian University of Athens, 'G. Gennimatas' General Hospital, 11527 Athens, Greece., Moschos MM; First Department of Ophthalmology, National and Kapodistrian University of Athens, 'G. Gennimatas' General Hospital, 11527 Athens, Greece. |
Jazyk: |
angličtina |
Zdroj: |
Journal of clinical medicine [J Clin Med] 2023 Oct 25; Vol. 12 (21). Date of Electronic Publication: 2023 Oct 25. |
DOI: |
10.3390/jcm12216732 |
Abstrakt: |
(1) Background: The current study aimed to compare two of the most frequently prescribed preservative-free (PF) antiglaucoma drops, (Latanoprost PF vs. Bimatoprost PF) in promoting OSD in patients with POAG. (2) Methods: In this prospective study, 44 eyes from 44 participants were included. In the control group we enrolled 24 eyes, 11 eyes treated only with Latanoprost PF were enrolled in the Latanoprost PF group, and 9 eyes treated only with Bimatoprost PF in the Bimatoprost PF group. In all eyes, we evaluated the ocular levels of MMP-9 using the InflammaDry kit. We also performed Schirmer's test and the TBUT test. (3) Results: We found elevated ocular levels of MMP-9 (>40 ng/mL) in the Bimatoprost PF group (88.89% of the participants) compared to the control (8.33%) and the Latanoprost PF group (27.27%), and the difference was statistically significant ( p < 0.001). The Schirmer's test values were statistically significantly lower in the Bimatoprost PF group compared to the other two groups. Additionally, the TBUT values were lower in the Bimatoprost PF group compared to the control group, and the difference was statistically significant. (4) Conclusions: Latanoprost PF eye drops treat the ocular surface better and they do not induce overexpression of MMP-9, a molecule that is related to OSD. |
Databáze: |
MEDLINE |
Externí odkaz: |
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|